These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 4591315

  • 21. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H, Werner E, Winsel K, Iwainsky H.
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
    [No Abstract] [Full Text] [Related]

  • 22. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K, Oizumi K, Yamada S, Ogata K, Sato M.
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract] [Full Text] [Related]

  • 23. [Comparative clinical evaluation of the treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin by the daily and intermittent methods].
    Zierski M, Bek E, Bergson H, Kucharska A, Strupczewska-Janusz H.
    Pneumonol Pol; 1977 Apr; 45(4):277-90. PubMed ID: 854460
    [No Abstract] [Full Text] [Related]

  • 24. [Microbiological evaluation of the abacillary state in the combined therapy of destructive pulmonary tuberculosis in experimental animals].
    Kunichan AD, Nemsadze MN.
    Probl Tuberk; 1982 Nov; (11):62-5. PubMed ID: 7156108
    [No Abstract] [Full Text] [Related]

  • 25. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
    Pandey R, Sharma S, Khuller GK.
    Tuberculosis (Edinb); 2005 Nov; 85(5-6):415-20. PubMed ID: 16256437
    [Abstract] [Full Text] [Related]

  • 26. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
    Kawakami K.
    Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
    [Abstract] [Full Text] [Related]

  • 27. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG, Chernousova LN, Andreevskaia SN, Nikolaeva GM.
    Probl Tuberk Bolezn Legk; 2004 Aug; (3):32-7. PubMed ID: 15338898
    [Abstract] [Full Text] [Related]

  • 28. [Comparative study of the treatment of pulmonary tuberculosis by a combination of rifampicin and isoniazid administered daily and twice weekly for a year].
    Decroix G, Kreis B, Sors C, Birenbaum J, Le Lirzin M, Canetti G.
    Rev Tuberc Pneumol (Paris); 1971 Aug; 35(1):39-54. PubMed ID: 5559724
    [No Abstract] [Full Text] [Related]

  • 29. [Chemotherapy of patients with chronic destructive pulmonary tuberculosis in cases of mycobacterial resistance to rifampicin and isoniazid].
    Bialik IB, Klimenko MT.
    Klin Med (Mosk); 1985 Dec; 63(12):42-7. PubMed ID: 3937942
    [No Abstract] [Full Text] [Related]

  • 30. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H, Werner E, Winsel K, Iwainsky H.
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4470836
    [No Abstract] [Full Text] [Related]

  • 31. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G, Krasheninnikova MA, Kolosovskaia VP, Chukanov VI.
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S, Sasaki M, Kobayashi T, Matsuda T.
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract] [Full Text] [Related]

  • 34. Rifampicin in combination with isoniazid in the treatment childhood tuberculosis.
    Rahaju NN, Sutoto, Rahaju N, Budiman I, Sutejo.
    Paediatr Indones; 1976 Sep; 16(11-12):544-53. PubMed ID: 1088375
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J.
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract] [Full Text] [Related]

  • 37. Short course treatment with two drugs, isoniazid plus rifampicin for six months: a controlled clinical trial with two treatment regimens.
    Dubra FA.
    Bull Int Union Tuberc; 1976 May; 51(1):61-4. PubMed ID: 1030314
    [No Abstract] [Full Text] [Related]

  • 38. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC, Lee YC.
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [Abstract] [Full Text] [Related]

  • 39. Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results.
    Grumbach F, Canetti G, Le Lirzin M.
    Tubercle; 1969 Sep; 50(3):280-93. PubMed ID: 4981497
    [No Abstract] [Full Text] [Related]

  • 40. [Investigation on bacteriological relapses in cases of pulmonary tuberculosis treated with INH and RFP--report of the 27th B series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Mochizuki K, Shigeto E, Kobayashi Y, Nagasawa S.
    Kekkaku; 1987 May; 62(5):265-80. PubMed ID: 3626256
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.